-40% OFF
Dragon Pharma, Europe
Ment 50
Injection · 50 mg/ml · 10 ml
$48.00
$80.00
You will save $32.00
Compound ID
Trestolone Acetate
Dosage
50–100 mg/day
Concentration
50 mg/mL
Drug Class
Injectable
Half-life
6–8 hours
Properties
Shipping
Not available in this combination
Product overview
Dragon Pharma Trestolone Acetate 50mg/mL — Next-Generation Injectable Anabolic for Rapid Mass Accretion, Extreme Strength & Progestogenic Potency
Dragon Pharma Trestolone Acetate 50mg/mL, widely recognized throughout advanced performance circles as Ment 50, represents the vanguard of synthetic anabolic-androgenic steroid development—a compound engineered for the experienced physique athlete who demands mass-building velocity and strength escalation that outpaces traditional bulking agents. Structurally distinct from both testosterone and dihydrotestosterone derivatives, Trestolone occupies a unique pharmacological niche as a 19-nor progestin with extraordinarily high androgen receptor affinity and potent myotrophic activity.
The acetate ester ensures rapid systemic onset, while the compound's dual agonism at androgen and progesterone receptors creates an anabolic environment capable of producing dramatic lean tissue gains, pronounced neuromuscular power increases, and a marked surge in libido within days of initiation. Dragon Pharma's independently verified 51.36mg per milliliter concentration—marginally exceeding the stated 50mg claim—delivers a pharmaceutical-grade product that advanced users can administer with confidence in both potency precision and manufacturing integrity.
What is Dragon Pharma Trestolone Acetate?
Trestolone Acetate is a synthetic 19-nortestosterone derivative classified as a potent anabolic-androgenic steroid with significant progestogenic activity. Unlike conventional AAS that trace their structural lineage to testosterone or DHT, Trestolone was developed through independent synthetic pathways, resulting in a compound that exhibits androgen receptor binding affinity believed to exceed that of endogenous testosterone while simultaneously activating progesterone receptors with comparable intensity to Nandrolone or Trenbolone.
The acetate ester, with its approximately 48–72 hour active half-life, necessitates frequent intramuscular administration to maintain stable plasma concentrations and minimize hormonal fluctuation. Critically, Trestolone does not undergo aromatization via the aromatase enzyme, yet its progestogenic character can stimulate estrogenic-like effects in sensitive tissues—a mechanistic distinction that demands specialized side-effect management distinct from standard aromatizing compounds.
Dragon Pharma's oil-based 50mg per milliliter injectable solution provides a precisely concentrated, sterile delivery vehicle for this formidable agent.
Key Benefits / Effects
- Accelerated Lean Hypertrophy: Users consistently report dramatic increases in lean muscle mass that frequently outpace traditional bulking steroids, with visible tissue accretion beginning within the first 7–10 days of administration.
- Explosive Raw Strength Surges: Near-immediate improvements in neuromuscular power output enable constant progressive overload, with users adding substantial load to major compound lifts throughout the cycle.
- Marked Libido Enhancement: The compound's potent androgenic signaling produces a pronounced, often immediate increase in sexual desire and erectile quality that distinguishes it from more suppressive alternatives.
- Improved Psychological Drive: Enhanced dopaminergic and androgenic tone frequently manifests as increased training aggression, mental focus, and overall sense of well-being during high-intensity sessions.
- Favorable Aesthetic Profile: Despite its formidable mass-building capacity, Trestolone produces a relatively lean, hard appearance when nutritional and cardiovascular protocols are optimized, with minimal estrogenic fluid retention.
- Versatile Phase Application: Effective in both aggressive bulking and body recomposition contexts, adapting to caloric surplus or deficit depending on the athlete's strategic objectives.
How Dragon Pharma Trestolone Acetate Works
Trestolone initiates its primary effects through ultra-high-affinity binding to androgen receptors in skeletal muscle tissue, activating genomic pathways that dramatically upregulate muscle protein synthesis, nitrogen retention, and satellite cell proliferation. The 19-nor structure confers strong anabolic character while the absence of a C19 methyl group prevents 5-alpha reductase interaction—meaning the compound cannot convert to DHT and maintains its full potency in tissues where other steroids would be attenuated.
Simultaneously, Trestolone functions as a potent progestin, binding to progesterone receptors with an affinity that parallels Nandrolone and Trenbolone. This dual-receptor activity amplifies the anabolic signal while introducing unique metabolic considerations, including potential prolactin elevation and progestogenic mammary tissue stimulation. The acetate ester undergoes rapid enzymatic hydrolysis in plasma, releasing free Trestolone quickly and producing measurable physiological changes within days rather than weeks.
The net result is a compound that generates exceptional myotrophic activity, aggressive strength adaptation, and pronounced androgenic effects with a pharmacological character distinct from both testosterone derivatives and traditional 19-nor compounds.
Usage Information
Dragon Pharma Trestolone Acetate is supplied as a 50mg per milliliter oil-based injectable solution, strictly intended for intramuscular administration by experienced male athletes. Due to the short acetate ester half-life, injections must be administered at minimum once daily, with ideally twice-daily dosing (every 12 hours) to maintain stable blood levels and minimize peak-trough fluctuations that can exacerbate side effects.
Standard daily dosages range from 25mg to 50mg, translating to 0.5–1.0mL of solution daily and yielding weekly totals of 175–350mg. Advanced users may explore higher ranges, though the extreme potency of Trestolone means that even conservative doses produce profound effects. Cycle duration is typically limited to 8–10 weeks due to the compound's intensity and suppressive nature.
A testosterone base is strongly recommended despite Trestolone's inherent potency, as exogenous testosterone supports physiological functions that Trestolone alone may not fully address. Prolactin management through dopamine agonists is essential, and comprehensive organ support, cardiovascular monitoring, and structured Post-Cycle Therapy are mandatory components of any protocol. Female use is absolutely contraindicated due to rapid and severe virilization risk.
Quality & Manufacturing
Dragon Pharma maintains exacting pharmaceutical manufacturing protocols, with each Trestolone Acetate batch subjected to independent third-party laboratory analysis to verify sterility, endotoxin absence, heavy metal screening, and active ingredient concentration. Recent analytical testing conducted in March 2024 confirmed an actual Trestolone content of 51.36mg per milliliter—a precise 102.7% of the stated 50mg claim.
This intentional overage policy reflects Dragon Pharma's commitment to ensuring users receive at minimum the full pharmacological payload required for predictable outcomes. Trestolone synthesis is notably complex, and the compound is particularly susceptible to degradation, underdosing, or contamination in unregulated environments. Dragon Pharma's sterile manufacturing environment, analytical transparency, and batch consistency provide advanced athletes with the confidence to program aggressive protocols knowing that each milliliter delivers exactly the intended potency without the dangerous variability of underground alternatives.
Possible Side Effects / Safety Information
- Progestogenic Gynecomastia Risk: Despite non-aromatization, Trestolone's potent progesterone receptor agonism can stimulate mammary tissue proliferation and lactation in sensitive individuals. Dopamine agonists such as Cabergoline are essential for prolactin suppression.
- Profound HPTA Suppression: Trestolone rapidly and completely shuts down endogenous testosterone production. A testosterone base during the cycle and aggressive Post-Cycle Therapy afterward are absolutely mandatory.
- Intense Androgenic Manifestations: Users frequently experience acne, accelerated male pattern baldness in genetically predisposed individuals, increased terminal hair growth, and heightened aggression or irritability.
- Cardiovascular Dyslipidemia: The compound can significantly depress HDL cholesterol while elevating LDL cholesterol and blood pressure, necessitating dietary omega-3 supplementation, regular cardiovascular exercise, and lipid monitoring.
- Prolactin-Mediated Sexual Dysfunction: Without proper dopamine agonist management, elevated prolactin can paradoxically cause erectile dysfunction, anorgasmia, or diminished libido despite the compound's inherent androgenic drive.
- Injection Site Management: The short ester requires frequent injections, increasing the risk of localized tissue irritation, post-injection pain, or scar tissue accumulation without diligent site rotation.
- Psychological Disturbances: Some users report mood instability, heightened anxiety, or sleep disruption consistent with strong progestogenic and androgenic activity.
- Absolute Female Contraindication: The extreme androgenic and progestogenic potency produces rapid, irreversible virilization; female use is categorically prohibited.
Why Choose Dragon Pharma Trestolone Acetate?
The Trestolone marketplace is fraught with degraded, underdosed, and bacterially contaminated products that compromise both results and user safety. Dragon Pharma's verified 51.36mg per milliliter potency, combined with sterile manufacturing standards and transparent third-party analytical disclosure, ensures that advanced athletes receive exactly the pharmacological payload required for this compound's legendary effects.
For bodybuilders who have plateaued on traditional testosterone and Nandrolone protocols and seek a next-generation anabolic agent with distinct receptor pharmacology, unprecedented mass-building velocity, and formidable strength enhancement, this formulation provides a calculated, verified platform. The brand's commitment to dosing accuracy transforms what could be a hazardous experiment into an informed, precision-engineered protocol for extreme physiological transformation.
Product FAQ
Questions, answered
Trestolone occupies a unique structural position outside the testosterone and DHT derivative families. While testosterone requires 5-alpha reduction to DHT for full androgenic expression and aromatizes readily to estrogen, Trestolone exhibits its full potency without conversion and does not interact with aromatase. Compared to Nandrolone, Trestolone demonstrates significantly higher androgen receptor binding affinity and more aggressive anabolic signaling, producing faster and more dramatic results. However, it shares Nandrolone's progestogenic liability, requiring similar prolactin management strategies. The overall effect is a compound that feels subjectively more potent than either traditional bulking agent while demanding more sophisticated ancillary support.
Despite Trestolone's formidable anabolic and androgenic activity, it does not perfectly replicate all physiological functions of endogenous testosterone. A low-dose testosterone base—typically 100–200mg weekly of Testosterone Propionate or Enanthate—ensures adequate estrogen levels for joint lubrication, mood stability, and cardiovascular health while Trestolone drives primary anabolic progress. Additionally, the testosterone base helps prevent the low-estrogen symptoms that can occur when stacking multiple non-aromatizing compounds, including dry joints and emotional flatness.
Due to the rapid acetate ester and Trestolone's extreme receptor affinity, users typically report subjective improvements in training aggression, libido, and muscle fullness within the first 3–5 days. Visible hypertrophic changes and strength increases generally consolidate by week 2, with dramatic mass accretion appearing between weeks 3 and 6. The short ester means that both benefits and side effects manifest more quickly than with longer-estered compounds like Testosterone Enanthate or Nandrolone Decanoate.
The acetate ester's approximately 48–72 hour active half-life necessitates at minimum once-daily injections, with ideally twice-daily administration (every 12 hours) for maximum stability. A common protocol divides the daily 25–50mg dose into two equal injections of 0.25–0.5mL, administered morning and evening. This split-dosing approach minimizes peak-trough hormonal fluctuation, reduces injection site volume per administration, and helps stabilize prolactin and estrogenic side effects that can worsen with variable plasma concentrations.
Trestolone stimulates gynecomastia through progestogenic rather than estrogenic pathways. As a potent progesterone receptor agonist, it can directly stimulate mammary tissue proliferation and upregulate prolactin secretion from the pituitary. Elevated prolactin further sensitizes breast tissue to any circulating estrogen and can induce lactation. This mechanism is distinct from aromatase-mediated gynecomastia and requires management through dopamine agonists like Cabergoline (0.25–0.5mg twice weekly) rather than aromatase inhibitors alone. Some users employ both AIs and dopamine agonists for comprehensive protection.
For aggressive bulking, Trestolone at 35–50mg daily serves as the primary anabolic driver, supported by a testosterone base at 200mg weekly to maintain physiological estrogen. Adding an oral kickstarter such as Methyldrostanolone at 20mg daily for the first 4 weeks can accelerate early results. Nandrolone Phenylpropionate at 300–400mg weekly may synergize with Trestolone's progestogenic activity for enhanced collagen synthesis and joint support, though prolactin management becomes even more critical. Comprehensive liver support, cardiovascular monitoring, and aggressive PCT are mandatory across all advanced stacks.
Yes. When combined with caloric restriction and cardiovascular training, Trestolone's non-aromatizing nature and potent nutrient partitioning effects can produce significant fat loss while preserving or even building lean tissue. The compound's ability to maintain strength during energy deficit is particularly valuable. However, the frequent injection schedule and prolactin management requirements make it less convenient than dedicated cutting agents like Drostanolone or Trenbolone Acetate. Users should monitor blood pressure closely, as hypocaloric states combined with strong androgenic activity can strain cardiovascular function.
PCT must be aggressive due to the depth of suppression. Because the acetate ester clears rapidly, therapy can begin 3–5 days after the final injection. A comprehensive protocol includes Clomiphene Citrate at 50/50/25/25mg and Tamoxifen Citrate at 40/20/20/20mg over four weeks. Given Trestolone's progestogenic nature, some practitioners extend PCT to 6 weeks or add HCG at 500–1000IU every other day for the two weeks preceding SERM initiation. Blood work confirming recovered LH, FSH, and total testosterone must precede any subsequent cycle.
Trestolone's progestogenic activity stimulates the pituitary to release prolactin, a hormone that in excess can cause gynecomastia, sexual dysfunction, fluid retention, and mood disturbances. Unlike estrogen, which is managed with aromatase inhibitors, prolactin requires dopamine agonist therapy. Cabergoline at 0.25–0.5mg administered twice weekly is the standard prophylactic approach, with some users requiring weekly dosing depending on individual sensitivity. Prolactin levels should be monitored mid-cycle, and any symptoms of nipple sensitivity, lactation, or sexual dysfunction warrant immediate dose adjustment or additional pharmacological intervention.
No. Trestolone is explicitly an advanced compound reserved for experienced users with multiple prior cycles and thorough understanding of prolactin management, cardiovascular monitoring, and complex ancillary protocols. The compound's extreme potency, unique side-effect profile, and requirement for daily injections make it unsuitable for novices. Beginners should develop their understanding of anabolic response, estrogen management, and PCT through traditional testosterone-only or mild oral cycles before considering Trestolone.
Comprehensive panels must include total and free testosterone, estradiol, prolactin, complete blood count with hematocrit, comprehensive metabolic panel with liver enzymes, and a full lipid profile. Baseline testing before cycle initiation establishes hormonal reference points. Mid-cycle testing at week 4–5 identifies emerging prolactin elevation, dyslipidemia, or hematocrit issues. Post-cycle panels at weeks 2 and 4 confirm recovery trajectory. Given Trestolone's aggressive impact on multiple physiological systems, these safeguards are absolutely non-negotiable.
Independent analytical verification confirming 51.36mg per milliliter demonstrates Dragon Pharma's commitment to delivering accurately dosed, slightly overfilled products rather than falling short of label claims. Generic or unverified Trestolone sources frequently contain 60–80% of stated concentration, or degraded active ingredient that has lost potency during improper storage or synthesis. This dosing uncertainty not only compromises mass-building and strength results but also makes side-effect management impossible to calibrate. Dragon Pharma's batch consistency ensures that users can program precise daily and weekly totals with mathematical confidence.
